Hikma Pharmaceuticals (HKMPF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Hikma Pharmaceuticals

PNK: HKMPF · Real-Time Price · USD
26.93
0.73 (2.80%)
At close: May 07, 2025, 12:33 PM

Hikma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
359M 285M 190M 146M 188M 346M 421M 467M
Depreciation & Amortization
199.89M 150M 190M 232M 185M 232M 169M 98M
Stock-Based Compensation
27M 30M 25M 22M 22M 23M 29M 29M
Other Working Capital
43M 90M 131M 6M -49M 12M 86M 8M
Other Non-Cash Items
191.11M 203M 211M 351M 282M 131M 61M 15M
Deferred Income Tax
n/a n/a n/a 1M 76M 138M 99M 192M
Change in Working Capital
-213M -84M -8M -168M -147M -149M -42M -213M
Operating Cash Flow
564M 584M 608M 583M 530M 583M 638M 396M
Capital Expenditures
-165M -154M -169M -159M -138M -143M -145M -171M
Cash Acquisitions
-150M -88M -98M -10M -373M -373M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-66M -78M -66M -51M -96M -124M -93M -116M
Investing Cash Flow
-381M -320M -333M -220M -607M -640M -238M -287M
Debt Repayment
47M 47M -14M -14M 692M 692M -25M -25M
Common Stock Repurchased
n/a n/a n/a n/a -300M -300M n/a -4M
Dividend Paid
-175M -159M -137M -124M -125M -125M -120M -114M
Other Financial Acitivies
-60M -179M -186M -309M -325M -151M -142M -47M
Financial Cash Flow
-188M -291M -337M -447M -58M 116M -287M -190M
Net Cash Flow
n/a 169M -65M -99M -156M 49M 103M -91M
Free Cash Flow
399M 430M 439M 424M 392M 440M 493M 225M